What happens when you take paroxetine with St. John's wort?
Paroxetine (Paxil, Pexeva, Brisdelle) is a selective serotonin reuptake inhibitor used for major depression, generalized anxiety disorder, panic disorder, social anxiety disorder, OCD, PTSD, and vasomotor symptoms of menopause. Pharmacologically it is one of the more potent SSRIs at the serotonin transporter and has some anticholinergic activity, contributing to a distinctive side-effect profile. St. John's wort (Hypericum perforatum) is a botanical product used for mild to moderate depression that contains hyperforin and hypericin, both of which inhibit serotonin (and norepinephrine and dopamine) reuptake.
When the two are taken together, the additive inhibition of serotonin reuptake can drive synaptic serotonin into the range where serotonin syndrome emerges - agitation, confusion, tremor, clonus, hyperreflexia, sweating, fever, tachycardia, hypertension, and in severe cases rigidity, seizures, and death. Published reviews of SSRI plus St. John's wort case series consistently identify paroxetine alongside sertraline as the most frequently implicated SSRIs.
There is also a metabolic interaction. St. John's wort is a strong inducer of CYP3A4, CYP2C9, CYP2C19, and P-glycoprotein. Paroxetine is metabolized primarily by CYP2D6, but enzyme induction by St. John's wort can still measurably affect paroxetine plasma levels through secondary pathways and protein transport. The net result is an unpredictable mix - serotonergic toxicity from pharmacodynamic stacking, partially offset by reduced drug exposure from induction.
Why is this important?
Paroxetine is one of the most commonly dispensed SSRIs worldwide. St. John's wort remains a popular over-the-counter botanical that patients reach for during low mood, often without realizing it should not be combined with an antidepressant they are already taking. The U.S. National Center for Complementary and Integrative Health (NCCIH) explicitly warns that combining St. John's wort with antidepressants can cause a potentially life-threatening increase in serotonin. The FDA labeling for paroxetine also lists serotonergic herbal products as agents to avoid concomitantly.
The clinical risk is not purely theoretical. Multiple peer-reviewed case reports describe patients who developed classic serotonin syndrome within days of adding St. John's wort to paroxetine. Paroxetine's relatively short half-life (around 21 hours) does not provide much safety margin: a patient can be in active interaction range continuously while taking the drug daily.
Paroxetine is also notorious for discontinuation syndrome - dizziness, electric-shock sensations, irritability, and flu-like symptoms when stopped abruptly. This raises the stakes for management: a patient cannot simply stop paroxetine cold turkey to make space for St. John's wort, and most clinicians would not recommend the swap anyway given the supplement's variable potency and pharmacokinetics.
What should you do?
If you take paroxetine, do not start St. John's wort. If you are currently taking both, contact your prescriber promptly. Do not stop paroxetine on your own. Seek emergency care if you have tremor, fever, fast heart rate, sweating, severe agitation, twitching, or muscle stiffness, and bring the supplement bottle so clinicians can see the product and dose.
If you and your prescriber decide that St. John's wort makes sense for you, the conservative approach is to discontinue paroxetine by taper (often over several weeks given paroxetine's discontinuation profile) and then wait at least 1-2 weeks of washout before introducing St. John's wort. Most psychiatrists would recommend a different evidence-based antidepressant over the supplement.
Disclose every supplement, tea, and herbal product to your prescribing clinician and pharmacist. Be alert to St. John's wort hidden in blends labeled as "mood," "calm," "emotional support," "women's wellness," or by Latin or regional names (Hypericum perforatum, Johanniskraut, millepertuis).
Which specific products are affected?
This warning covers paroxetine in all brand and generic forms: Paxil, Paxil CR (controlled-release), Pexeva, Brisdelle (used for menopausal hot flashes), and authorized generics. On the supplement side, the warning applies to all Hypericum perforatum products: capsules, tablets, tinctures, teas, and standardized extracts (often labeled 0.3% hypericin or 3-5% hyperforin). Combination products marketed for stress, sleep, or mood may contain St. John's wort even when it is not the headline ingredient.
Other serotonergic agents that compound risk include other SSRIs and SNRIs, tramadol, triptans, fentanyl, MDMA, dextromethorphan, linezolid, MAO inhibitors, lithium, tryptophan, and 5-HTP. Patients on paroxetine should treat any new serotonergic exposure as a discussion point with their prescriber.
The bottom line
Paroxetine plus St. John's wort is one of the best-documented SSRI plus botanical interactions and is classified as a major or contraindicated pairing by drug-interaction references. The combination can cause serotonin syndrome and may also alter drug exposure through CYP induction. If you take paroxetine, avoid St. John's wort and discuss any herbal product with your prescriber before adding it.